Table 2.
Univariate analysis of clinicopathological factors for OS in 164 colorectal cancer (CRC) patients
| Characteristics | Overall Survival (OS) | ||
|---|---|---|---|
| Hazard ratio | 95% CI | P value | |
| Age:>60 versus ≤60 | 0.856 | 0.520,1.409 | 0.541 |
| Gender: female versus male | 1.306 | 0.783,2.178 | 0.306 |
| Tumor location: rectum versus colon | 1.437 | 0.864,2.390 | 0.162 |
| Tumor size:>5 versus ≤5 cm | 1.270 | 0.700,2.306 | 0.432 |
| Gross appearance: ulcerative versus exophytic | 1.606 | 0.942,2.738 | 0.082 |
| Histological type: mucinous adenocarcinoma versus adenocarcinoma | 1.981 | 1.054,3.726 | 0.034 |
| Tumor differentiation: poor and others versus well, moderate | 1.772 | 1.038,3.023 | 0.036 |
| T:T3, T4 versus T1, T2 | 2.255 | 0.971,5.235 | 0.059 |
| Lymph node metastasis: positive versus negative | 2.740 | 1.649,4.553 | <0.001 |
| Distant metastasis: M1 versus M0 | 5.479 | 3.065,9.794 | <0.001 |
| TNM Stage: III+IV versus I+II | 3.994 | 2.335,6.834 | <0.001 |
| Liver metastasis: positive versus negative | 5.362 | 3.234,8.889 | <0.001 |
| CEA:>5 versus ≤5 ng/mL | 1.947 | 1.180,3.210 | 0.009 |
| MSI‐2 expression: high versus low | 2.888 | 1.750,4.766 | <0.001 |
Bold values (P < 0.05) are statistically significant.
CI, confidence interval.